🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute vaso-occlusive crisis (VOC) is the most common complication in patien...
Status
Recruiting
Location
Methodist Comprehensive Sickle Cell Center
Start Date
2018-02-05
Trial ID
NCT03353584
Treatments Being Tested
Sickle Cell Disease is a serious disease that is life-threatening for patie...
Status
Completed
Location
CHU Brugmann
Start Date
2012-11
Trial ID
NCT02386657
Treatments Being Tested
This is an observational study to improve the treatment of patients with Si...
Status
Unknown
Location
Tampa General Hospital
Start Date
2022-03-30
Trial ID
NCT05388188
Treatments Being Tested
Prospective phase IV interventional open label randomized controlled trial ...
Status
Completed
Location
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Start Date
2022-01-04
Trial ID
NCT05371184
Treatments Being Tested
Vaso-occlusive crisis in Sickle cell disease might alter myocardial functio...
Status
Unknown
Location
Medical Intensive Care Unit
Start Date
2021-01-01
Trial ID
NCT04864041
Treatments Being Tested
This study is being done to learn more about a possible new treatment for p...
Status
Not Yet Recruiting
Location
Children's National Hospital
Start Date
2025-07-25
Trial ID
NCT06989567
Treatments Being Tested
Pediatric patients who present with acute vaso-occlusive pain crisis may ha...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06579703
Treatments Being Tested
Sickle cell disease (SCD) is a genetic blood disorder. Crizanlizumab is ind...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-14
Trial ID
NCT04662931
Treatments Being Tested
Treatment of painful vaso-occlusive crises, the most common manifestation o...
Status
Unknown
Location
Avicenne University Hospital
Start Date
2018-09-28
Trial ID
NCT03639805
Treatments Being Tested
Sickle cell disease (SCD) is characterized by recurrent vaso-occlusive pain...
Status
Recruiting
Location
Henri Mondor
Start Date
2020-04-27
Trial ID
NCT03976180